Status:
UNKNOWN
The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressure
Lead Sponsor:
University of Aarhus
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
55-75 years
Phase:
PHASE4
Brief Summary
Melatonin protects your bones while losing fat! This was previously demonstrated by our group. The mechanisms behind these findings are still elusive, and the aim of the present study is to assess the...
Eligibility Criteria
Inclusion
- Post-menopausal women between 55 and 75 years
Exclusion
- Severely impaired renal function
- Severely impaired hepatic function
- Coagulation factors PP\<0.6
- Hypercalcemia (p-ion calcium \>1.32 nmol/l)
- Previous or present malignancies (except a treated skin cancer that is not melanoma or treated carcinoma in situ, 2 years since last therapy)
- Diseases affecting the calcium homeostasis including untreated thyroid diseases
- Regular use of medicine affecting the calcium homeostasis, including diuretics, fenemal, lithium, antiepileptica and glucosteroids
- Selective serotonin reuptake inhibitor (SSRI)-products with fluvoxamin
- Treatment with carbamazepin
- Treatment with rifampicin
- Severe malabsorption syndrome including gastric or intestinal resection
- Alcohol or drug abuse
- Smokers
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04864509
Start Date
May 1 2021
End Date
June 1 2024
Last Update
April 29 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.